Episode

Redefining Life with Friedreich Ataxia

Podcast
Amplifying the Patient Journey
Published
Nov 20, 2024
Duration seconds
701
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/BMCL2143886497.mp3?updated=1731071392
Audio
https://traffic.megaphone.fm/BMCL2143886497.mp3?updated=1731071392
JSON
/v1/public/podcasts/amplifying-the-patient-journey-6685265/episodes/redefining-life-with-friedreich-ataxia
Markdown
/podcast/amplifying-the-patient-journey-6685265/redefining-life-with-friedreich-ataxia.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/amplifying-the-patient-journey-6685265/episodes/redefining-life-with-friedreich-ataxia/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/amplifying-the-patient-journey-6685265/redefining-life-with-friedreich-ataxia.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

We speak with neuromuscular disease expert David Lynch, MD, PhD, attending neurologist in the Division of Neurology at Children's Hospital of Philadelphia and director of the Friedreich Ataxia Program, about the emerging treatment landscape for Friedeich Ataxia as well as Kiersten Riggs, who discusses the events leading to her Friedrich Ataxia diagnosis and how she has adapted to life with Friedrich ataxia.